Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -8.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -8.26% | |||
| Cost of Revenue | 0.00% | -4.18% | |||
| Gross Profit | 0.00% | -10.79% | |||
| SG&A Expenses | 0.00% | -6.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | -50.86% | |||
| Total Operating Expenses | 0.00% | -6.24% | |||
| Operating Income | 0.00% | -33.89% | |||
| Income Before Tax | 0.00% | -33.83% | |||
| Income Tax Expenses | 0.00% | 24.40% | |||
| Earnings from Continuing Operations | 0.00% | -42.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -84.24% | |||
| Net Income | 0.00% | -54.66% | |||
| EBIT | 0.00% | -33.89% | |||
| EBITDA | 0.00% | -24.21% | |||
| EPS Basic | 0.00% | -54.30% | |||
| Normalized Basic EPS | 0.00% | -32.89% | |||
| EPS Diluted | 0.00% | -54.97% | |||
| Normalized Diluted EPS | 0.00% | -32.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||